(Approval lapsed) Dantrium Intravenous 20 mg dantrolene sodium Powder for Solution for Injection
Section 19A approved medicine
(Approval lapsed) Dantrium Intravenous 20 mg dantrolene sodium Powder for Solution for Injection
Section 19A approval holder
Pfizer Australia Pty Ltd ABN 50 008 422 348
Phone
1800 675 229
Approved until
Status
Expired
Medicines in short supply/unavailable
DANTRIUM dantrolene sodium hemiheptahydrate 20mg powder for injection vial - ARTG 14435
Indication(s)
For the treatment of malignant hyperthermia.